Minimum Clinically Important Difference of Gross Motor Function and Gait Endurance in Children with Motor Impairment: A Comparison of Distribution-Based Approaches

Joint Authors

Strazzer, Sandra
Beretta, Elena
Panzeri, Daniele
Reni, Gianluigi
Storm, Fabio Alexander
Petrarca, Maurizio
Piccinini, Luigi
Maghini, Cristina
Corbetta, Claudio
Morganti, Roberta
Frascarelli, Flaminia
Colazza, Alessandra
Cordone, Giampietro
Biffi, E.
Castelli, E.

Source

BioMed Research International

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-9, 9 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-05-16

Country of Publication

Egypt

No. of Pages

9

Main Subjects

Medicine

Abstract EN

Objective.

The minimum clinically important difference (MCID) is a standard way of measuring clinical relevance.

The objective of this work was to establish the MCID for the 6-minute walking test (6minWT) and the Gross Motor Function Measure (GMFM-88) in pediatric gait disorders.

Methods.

A cohort, pretest-posttest study was conducted in a hospitalized care setting.

A total of 182 patients with acquired brain injury (ABI) or cerebral palsy (CP) performed 20 robot-assisted gait training sessions complemented with 20 sessions of physical therapy over 4 weeks.

Separate MCIDs were calculated using 5 distribution-based approaches, complemented with an anonymized survey completed by clinical professionals.

Results.

The MCID range for the 6minWT was 20-38 m in the ABI cohort, with subgroup ranges of 20-36 m for GMFCS I-II, 23-46 m for GMFCS III, and 24-46 m for GMFCS IV.

MCIDs for the CP population were 6-23 m, with subgroup ranges of 4-28 m for GMFCS I-II, 9-19 m for GMFCS III, and 10-27 m for GMFCS IV.

For GMFM-88 total score, MCID values were 1.1%-5.3% for the ABI cohort and 0.1%-3.0% for the CP population.

For dimension “D” of the GMFM, MCID ranges were 2.3%-6.5% and 0.8%-5.2% for ABI and CP populations, respectively.

For dimension “E,” MCID ranges were 2.8%-6.5% and 0.3%-4.9% for ABI and CP cohorts, respectively.

The survey showed a large interquartile range, but the results well mimicked the distribution-based methods.

Conclusions.

This study identified for the first time MCID ranges for 6minWT and GMFM-88 in pediatric patients with neurological impairments, offering useful insights for clinicians to evaluate the impact of treatments.

Distribution-based methods should be used with caution: methods based on pre-post correlation may underestimate MCID when applied to patients with small improvements over the treatment period.

Our results should be complemented with estimates obtained using consensus- and anchor-based approaches.

American Psychological Association (APA)

Storm, Fabio Alexander& Petrarca, Maurizio& Beretta, Elena& Strazzer, Sandra& Piccinini, Luigi& Maghini, Cristina…[et al.]. 2020. Minimum Clinically Important Difference of Gross Motor Function and Gait Endurance in Children with Motor Impairment: A Comparison of Distribution-Based Approaches. BioMed Research International،Vol. 2020, no. 2020, pp.1-9.
https://search.emarefa.net/detail/BIM-1132722

Modern Language Association (MLA)

Storm, Fabio Alexander…[et al.]. Minimum Clinically Important Difference of Gross Motor Function and Gait Endurance in Children with Motor Impairment: A Comparison of Distribution-Based Approaches. BioMed Research International No. 2020 (2020), pp.1-9.
https://search.emarefa.net/detail/BIM-1132722

American Medical Association (AMA)

Storm, Fabio Alexander& Petrarca, Maurizio& Beretta, Elena& Strazzer, Sandra& Piccinini, Luigi& Maghini, Cristina…[et al.]. Minimum Clinically Important Difference of Gross Motor Function and Gait Endurance in Children with Motor Impairment: A Comparison of Distribution-Based Approaches. BioMed Research International. 2020. Vol. 2020, no. 2020, pp.1-9.
https://search.emarefa.net/detail/BIM-1132722

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1132722